Botox A Injection for Pain after Laparoscopic Ventral Hernia: A Case Report

Pain Medicine

Volumn 12, Issue 7, 2011, Pages 1121-1123

  Smoot, Dustin ^a   Zielinski, Martin ^a   Jenkins, Donald ^a   Schiller, Henry ^a  

^a MAYO CLINIC   (United States)

Author keywords

Botulinum Toxin A; Surgery

Indexed keywords

BOTULINUM TOXIN A; NARCOTIC ANALGESIC AGENT; PARACETAMOL;

ABDOMINAL WALL HERNIA; ABDOMINAL WALL MUSCULATURE; ADULT; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; HERNIOPLASTY; HUMAN; LAPAROSCOPIC SURGERY; PAIN ASSESSMENT; POSTOPERATIVE PAIN; TREATMENT OUTCOME;

EID: 79960381374     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01147.x     Document Type: Article

References (21)

1. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol 2002;249(12):1729-32.
2. Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain 2002;18:S142-6.
3. Nelson L, Bachoo P, Holmes J. Botulinum toxin type B: A new therapy for axillary hyperhidrosis. Br J Plast Surg 2005;58(2):228-32.
4. Cheng CM, Chen JS, Patel RP. Unlabeled uses of botulinum toxins: A review, part 1. Am J Health Syst Pharm 2006;63(2):145-52.
5. Cheng CM, Chen JS, Patel RP. Unlabeled uses of botulinum toxins: A review, part 2. Am J Health Syst Pharm 2006;63(3):225-32.
6. Brin MF, Boodhoo TI, Pogoda JM, etal. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 patients. J Am Acad Dermatol 2009;61(6):961-70.
7. Figus A, Mazzocchi M, Dessy LA, etal. Treatment of muscular contraction deformities with botulinum toxin type A after latissimus dorsi flap and sub-pectoral implant breast reconstruction. J Plast Reconstr Aesthet Surg 2009;62(7):869-75.
8. Layeeque R, Hochberg J, Siegel E, etal. Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann Surg 2004;240(4):608-13.
9. Smith HS, Audette J, Royal MA. Botulinum toxin in pain management of soft tissue syndromes. Clin J Pain 2002;18:S147-54.
10. Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002;18:S125-32.
11. Setler PE. Therapeutic use of botulinum toxins: Background and history. Clin J Pain 2002;18:S119-24.
12. de Ru JA, Buwaldwa J. Botulinum toxin A injection into corrugator muscle for frontally localized chronic daily headache or chronic tension-type headache. J Laryngol Otol 2009;123(4):412-7.
13. Jin L, Kollewe K, Krampfl K, etal. Treatment of phantom limb pain with botulinum toxin type A. Pain Med 2009;10(2):300-3.
14. Mahowald ML, Krug HE, Singh JA, Dykstra D. Intra-articular bolulinum toxin type A: A new approach to treat arthritis joint pain. Toxicon 2009;54(5):658-67.
15. Chien KH, Lu DW, Chen YH, Cheng JH, Chen JT. Relief of periorbital pain after acute angle closure glaucoma attack by botulinum toxin type A. J Glaucoma 2010;19(8):546-50.
16. Wittekindt C, Wei-Chi L, Preuss S, Guntinas-Lichius O. Botulinum toxin A for neuropathic pain after neck dissection: A dose-finding study. Laryngoscope 2006;116:1168-71.
17. Zhibo X, Miaobo Z. Botulinum toxin type A infiltration for pain control after breast augmentation. Plast Reconstr Surg 2009;124(5):263e-4e.
18. Hamdy R, Montepetit K, Raney E, etal. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: A pilot study. J Pediatr Orthop 2009;29:427-34.
19. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: A randomized double blind study. Neurology 2001;56:1290-3.
20. Vuilleumier H, Hubner M. Neuropathy after herniorrhaphy: Indications for surgical treatment and outcome. World J Surg 2009;33:841-5.
21. Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE, etal. Use of botulinum toxin a before abdominal wall hernia reconstruction. World J Surg 2009;33:2553-6.